Bayzed Health Group - Public Comps and Valuation Multiples

Bayzed Health Group Overview

About Bayzed Health Group

Bayzed Health Group Inc is an oncology healthcare group that principally engages in the investment in, and provision of, medical and healthcare related services in the PRC. It operates and manages a network of eight hospitals in Beijing, Tianjin, Shanxi Province, Anhui Province and Henan Province with strategic focus on provision of full-cycle oncology healthcare services, through its direct ownership in the equity interest in six private for-profit hospitals and management over two private not-for-profit hospitals.

Founded

2021

HQ

Employees

2.1K+

Website

bayzedhealthcare.com

Sectors

Health Data & Analytics

Financials

Last FY Revenue $152M

Last FY EBITDA $15.7M

EV

$1.9B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Bayzed Health Group Financials

See Bayzed Health Group valuation multiples based on analyst estimates

Bayzed Health Group P&L

In the most recent fiscal year, Bayzed Health Group reported revenue of $152M and EBITDA of $15.7M.

Bayzed Health Group expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Bayzed Health Group valuation multiples based on analyst estimates

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$152M	XXX	XXX	XXX
Gross Profit	XXX	$26.7M	XXX	XXX	XXX
Gross Margin	XXX	18%	XXX	XXX	XXX
EBITDA	XXX	$15.7M	XXX	XXX	XXX
EBITDA Margin	XXX	10%	XXX	XXX	XXX
EBIT	XXX	$4.1M	XXX	XXX	XXX
EBIT Margin	XXX	3%	XXX	XXX	XXX
Net Profit	XXX	-$1.7M	XXX	XXX	XXX
Net Margin	XXX	-1%	XXX	XXX	XXX
Net Debt	XXX	$10.9M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Bayzed Health Group including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, Bayzed Health Group achieved $152M in revenue and $15.7M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	Analyst estimates available to subscribers	$152M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$26.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	17.5% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	$15.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	10.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	$4.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	2.7% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	-$1.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	-1.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	$10.9M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Bayzed Health Group

This financial data table provides comprehensive performance metrics for Bayzed Health Group, a company based in Hong Kong. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, Bayzed Health Group reported $152M in total revenue.
Fiscal year EBITDA was $15.7M.
The company maintained a gross profit margin of 17.5% in the most recent fiscal year.
EBITDA margin for the fiscal year was 10.3%.
Net profit margin reached -1.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Bayzed Health Group. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Bayzed Health Group Stock Performance

Bayzed Health Group has current market cap of HKD 15.4B (or $2.0B), and EV of HKD 15.1B (or $1.9B).

Market Cap Evolution

Bayzed Health Group Stock Data

As of September 17, 2025, Bayzed Health Group's stock price is HKD 12 (or $1).

See Bayzed Health Group trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.9B	$2.0B	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Bayzed Health Group Valuation Multiples

Bayzed Health Group's trades at 12.7x EV/Revenue multiple, and 123.9x EV/EBITDA.

See valuation multiples for Bayzed Health Group and 15K+ public comps

Bayzed Health Group Financial Valuation Multiples

As of September 17, 2025, Bayzed Health Group has market cap of $2.0B and EV of $1.9B.

Equity research analysts estimate Bayzed Health Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Bayzed Health Group's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$2.0B	XXX	$2.0B	XXX	XXX	XXX
EV (current)	$1.9B	XXX	$1.9B	XXX	XXX	XXX
EV/Revenue	n/a	XXX	12.7x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	123.9x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	474.7x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	-1145.3x	XXX	XXX	XXX
EV/FCF	n/a	XXX	124.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Bayzed Health Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Bayzed Health Group Margins & Growth Rates

Bayzed Health Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $11K for the same period.

Bayzed Health Group's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Bayzed Health Group's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Bayzed Health Group and other 15K+ public comps

Bayzed Health Group Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	10%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$11K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	0%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	15%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial